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Vitamin K policies and midwifery practice:
questionnaire survey
Pat Ansell, Eve Roman, Nicola T Fear, Mary J Renfrew
Abstract
Objectives To investigate policies on neonatal vitamin
K and their implementation.
Design Two phase postal survey.
Setting United Kingdom.
Participants A 10% random sample of midwives
registered with the United Kingdom Central Council
for nursing, midwifery, and health visiting. Of 3191
midwives in the sample, 2515 (79%) responded to
phase one and 2294 (72%) completed questionnaires
on their current jobs (November 1998 to May 1999).
In phase two, 853 (62%) of 1383 eligible midwives
gave details on 2179 of their earliest jobs (start dates
before 1990).
Results All the midwives in clinical practice at the
time of the survey (2271, 99%) reported that they
were working in areas with official policies on
neonatal vitamin K. Seven distinct policies were
described: intramuscular vitamin K for all babies
(1159, 51.0%); intramuscular vitamin K for babies at
“high risk,” oral for others (470, 20.7%); oral vitamin K
for all babies (323, 14.2%); parental choice for all (124,
5.5%); parental choice for all except babies at high
risk, (119, 5.2%); intramuscular vitamin K for babies at
high risk only (33, 1.5%); oral vitamin K for babies at
high risk only (17, 0.7%); and a disparate group of
policies including intravenous vitamin K for some
babies (26, 1.1%). Previous policies were (and some
may still be) open to individual interpretation and
were not always followed.
Conclusions Hospital policy is not necessarily a good
guide to individual practice. The primary purpose of
clinical records is to document patient care, and
recording practices reflect this. There is considerable
variation in vitamin K policies and midwifery practice
in the United Kingdom, and there is no clear
consensus on which babies should receive vitamin K
intramuscularly.
Introduction
Concern over prophylactic administration of vitamin
K to newborn babies has continued for almost a
decade, following reports in the early 1990s of a statis›
tically significant association between intramuscular
vitamin K and childhood cancer.1 Subsequent studies
have, in general, failed to support this association.2–10
Inconsistencies in results from the United Kingdom in
particular have, however, left lingering doubts about
the safety of administering vitamin K by the intramus›
cular route.1 6–10
Most British studies have had a case›control design,
with exposure data collected retrospectively from
maternity records.1 6 7 9 10 Details of vitamin K adminis›
tration may be found in several places in maternity
records,6 and all studies report that a written record
confirming that it has (or has not) been given is often
not found. Some research groups have attempted to
impute a child’s vitamin K status from the hospital
policy in place at the time of the child’s birth. Vitamin
K is, however, unique among drugs given to newborn
babies—although policies have customarily been
decided by paediatricians, a midwife has usually made
the final decision to give vitamin K to a healthy baby.
Three assumptions underpin imputation of vita›
min K status: that previous policies are accurately
recalled by current staff; that policies were followed
rigidly; and that vitamin K was often given without a
record being made. Anecdotal reports from midwives
and paediatricians suggest, however, that official
policies were not always followed. If true, this has seri›
ous implications for interpreting studies investigating
neonatal vitamin K status. Furthermore, continuing
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controversy over vitamin K is having deleterious effects
on babies, parents, midwives, and paediatricians.11–14
This two phase postal survey of midwives had two
aims: to assess the validity of imputing vitamin K status
from hospital policy and to investigate the impact of
the controversy on current vitamin K polices and mid›
wifery practice in the United Kingdom.
Methods
In September 1998 a 10% random sample of midwives
registered as practising in the United Kingdom was
selected from the professional register by the United
Kingdom Central Council for nursing, midwifery, and
health visiting. Questionnaires were posted directly to
midwives by the central council, and names and
addresses were not disclosed to the research team.
Midwives could, however, add their names and contact
details to the completed questionnaires.
In phase one, all midwives in the sample were sent
a questionnaire, a postage›paid return envelope, and a
letter describing the study. A freephone telephone
number was provided for resolution of queries. The
first questionnaire collected, among many other items,
data on current vitamin K policies and their
implementation. Questionnaires were posted in
November 1998, and reminders were sent to
non›responders in February and May 1999.
Midwives who returned completed questionnaires,
who qualified before 1990 (the year of the first report
suggesting a possible link between vitamin K and
childhood cancer), and who could be contacted again
were eligible for phase two. These midwives were sent
an additional questionnaire requesting information on
recording practices and whether policies were followed
in their earliest jobs (up to four). No reminders were
sent to non›responders in phase two.
Questionnaires were checked on receipt, and
queries were resolved by discussion with respondents
who provided contact information. Data were coded
and entered into Microsoft Access databases designed
for the study. Analyses were carried out using Access
and the statistical software package Stata 6.0 (Stata
Corporation, College Station, TX).
Results
Response
Of 3191 midwives surveyed, 2515 (79%) replied to
phase one and 2294 (72%) completed questionnaires.
The age distribution of midwives who completed
questionnaires (respondents) closely matched that of all
practising midwives on the professional register (statisti›
cal analysis of the United Kingdom Central Council’s
professional register—reports dated July 1998 and
November 1999). Distribution of respondents by health
region, compared with that of all midwives in post in the
NHS at 30 September 1998, is shown in the figure.15–18
Most respondents (89.1%; 2045) were, at the time of
the survey, working in general midwifery posts caring for
mothers and babies. Of the remainder, 4.6% (106) were
senior midwives or managers, 1.9% (44) were midwifery
teachers, 1.7% (38) worked in special care nurseries,
2.0% (47) had specialist or research posts, and 0.6% (14)
did not state their current job. All midwives who
reported that they were currently in clinical practice
(2271; 99%) were working in areas with an official
vitamin K policy. In phase two, 853 (62%) of the 1383
eligible midwives returned completed questionnaires.
Vitamin K policies
Policies in midwives’ current jobs (November 1998 to
May 1999) are detailed in table 1. Seven distinct
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Table 1 Vitamin K policies in midwives’ current jobs (November 1998 to May 1999),
with criteria for including babies in group at “high risk” if policy selective
Percentage (No)
Jobs with an official policy specifying route of administration (n=2271)
Vitamin K given by one route only:
Intramuscular for all babies 51.0 (1159)
Oral for all babies 14.2 (323)
Intramuscular for babies at high risk* only 1.5 (33)
Oral for babies at high risk* only 0.7 (17)
Vitamin K given by more than one route:
Intramuscular for babies at high risk*, oral for all others 20.7 (470)
Parents choose route and/or if vitamin K given 5.5 (124)
Parents choose route and/or if given unless high risk* 5.2 (119)
Other selective policies 1.1 (26)
Selective policies including each criterion (n=665)
Premature birth† 64.5 (429)
Difficult instrumental delivery (for example, high forceps) 56.4 (375)
Admission to neonatal unit/special care nursery 53.2 (354)
Birth trauma 46.9 (312)
Breech delivery 34.9 (232)
Caesarean section‡ 34.9 (232)
Easy instrumental delivery (for example, low forceps) 32.5 (216)
Birth asphyxia§ 33.2 (221)
Maternal anticonvulsants 25.4 (169)
Small for gestational age 13.4 (89)
Breast feeding 9.3 (62)
Jaundice 8.9 (59)
Antibiotics prescribed 3.5 (23)
Ventilated or unable to take oral feeds 2.9 (19)
Poor feeding 2.7 (18)
Circumcision 2.4 (16)
Maternal antituberculosis drugs 0.8 (5)
Other illness in mother or baby 19.8 (132)
Paediatrician’s clinical judgment 1.8 (12)
Unknown, no criteria given 3.6 (24)
*Considered at high risk of haemorrhagic disease.
†Gestation varies: <37 weeks (53), <36 (149), <34 (66), <32 (22), <30 (7), <28 (5), unknown (127).
‡Emergency caesarean section only in one job.
§One or more of the following criteria specified: birth asphyxia, low Apgar score, fetal distress, meconium
liquor.
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policies were described; the most common policy was
intramuscular vitamin K for all babies (51.0%; 1159).
Overall, in 96.7% (2195) of jobs with an official policy,
the policy specifies some form of vitamin K for all
babies, if parents consent.
Also shown in table 1 are criteria for including
babies in the group at “high risk” if policies are
selective. Criteria included in more than 50% of
policies were premature birth (64.5%; 429), difficult
instrumental delivery (for example, high forceps)
(56.4%; 375), and admission to a neonatal intensive or
special care nursery (53.2%; 354). Other complicated
or instrumental deliveries were included less fre›
quently: breech delivery, 34.9% (232); caesarean
section, 34.9% (232); and easy instrumental delivery
(for example, low forceps), 32.5% (216). Interestingly, a
paediatrician’s clinical judgment was specified as a cri›
terion in 1.8% (12) of policies.
There is considerable variation in the combinations
of criteria included in individual policies, with more
than one criterion applying to some babies—for exam›
ple, premature birth and admission to a neonatal nurs›
ery. Additionally, definitions of some criteria vary from
one policy to another; the gestation below which
babies were considered to be at high risk, for example,
ranged from < 37 weeks (53 policies) to < 36 (149),
< 34 (66), < 32 (22), < 30 (7), and < 28 weeks (5), with
gestation not stated for 127.
Implementation of current policies
Of the 2271 midwives whose current job had an official
policy, 81.8% (1858) reported that the policy was
always followed, with 14.3% (326) reporting that it was
not and 3.8% (87) being unsure (table 2). The main
reason given for not following official policy was
parental refusal or insistence on an oral preparation
(88.0%; 287), followed by paediatricians (8.0%; 26) and
midwives (2.1%; 7) using their own clinical judgment
and general practitioners’ refusal to prescribe an oral
preparation (0.6%; 2).
Also shown in table 2 are the places and number of
times each dose of vitamin K may have been recorded.
The places reported most often were neonatal records
or notes (80.1%; 1818) and mothers’ obstetric notes
(73.4%; 1666). In only 10.6% (241) of jobs was vitamin
K administration recorded once only, with each dose
reported as recorded in five or more places by 24.4%
(555) of midwives.
Reported recording practices for vitamin K admin›
istration (given or not given) in current jobs are shown
in table 3. Of the 2271 midwives whose current job had
an official policy, 99.3% reported that vitamin K was
usually recorded if given, 93.6% that route of adminis›
tration was also recorded, and 86.5% that a record was
made when vitamin K was not given. However, there is
some evidence of variation by policy type—“not given”
was reported as recorded by 63.2% if the policy was to
give vitamin K to babies at high risk only, by 85.6% if
vitamin K was to be given to all babies by the same
route, and by 91.0% if it was to be given to all babies but
by differing routes.
Implementation of historical policies
Details of 2179 previous jobs (held before 1990) were
given in phase two; overall, only 8.5% (185) of these
were reported as having no policy on vitamin K. How›
ever, midwives were unsure if there had been a policy
for an additional 21.7% (473). Although for a minority
of these jobs (14.4%) midwives were unable to remem›
ber the details of vitamin K administration, for most
(85.6%) some details were given but midwives were
unsure if it was an official policy.
The overall proportion of previous jobs reported
to have definitely had official policies was 69.8%
(1521/2179), but this increased gradually over the
years from 50.2% (300/598) for those that ended in
1979 or earlier to 86.8% (613/706) for those that
ended in 1990 or later. Of these 1521 jobs, policies
were reported as always having been followed in
68.8%, a record was made when vitamin K was given in
90.9%, and a record was made when vitamin K was not
given in 55.4% (table 4). The level of recording seems
Table 2 Implementation of policies on administration of vitamin
K in midwives’ current jobs (November 1998 to May 1999)
Percentage (No)
(n=2271)
Policy always followed:
Yes 81.8 (1858)
No 14.3 (326)
Not sure 3.8 (87)
Reasons policy not followed:
Parents refused or insisted on an oral preparation 88.0 (287)
Paediatricians used their own clinical judgment 8.0 (26)
Midwives used their own clinical judgment 2.1 (7)
General practitioner refused to prescribe oral preparation 0.6 (2)
Not stated 1.2 (4)
Places vitamin K is recorded:
Neonatal record or separate neonatal notes 80.1 (1818)
Maternal obstetric notes 73.4 (1666)
Discharge summary 52.8 (1199)
Midwifery notes or Kardex (mother’s or baby’s) 51.7 (1174)
Name tag on baby’s cot 27.6 (627)
Baby’s observation, care, or feed charts 27.0 (614)
Baby’s personal drug/vitamin K chart or form 8.4 (191)
Special vitamin K register 0.4 (9)
Number of times or places each dose is recorded:
1 10.6 (241)
2 18.7 (425)
3 24.3 (552)
4 21.4 (487)
>5 24.4 (555)
Not stated 0.5 (11)
Table 3 Recording practices reported for current vitamin K policies (November 1998 to May 1999). Values are percentages
(numbers)
Recording practice All policies (n=2271)
Vitamin K given to all babies Vitamin K given only to
babies at “high risk” (n=76)By the same route (n=1482) By different routes (n=713)
Recorded if given: 99.3 (2256) 99.4 (1473) 99.2 (707) 100 (76)
Route recorded 93.6 (2125) 91.3 (1353) 97.6 (696) 100 (76)
Recorded if not given 86.5 (1965) 85.6 (1268) 91.0 (649) 63 (48)
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to have improved over time, but the likelihood that a
policy was followed seems to have fallen.
Discussion
This survey of midwives differs from the two previous
British surveys of vitamin K prophylaxis in several
important ways. In the previous surveys information
about vitamin K policies was obtained from postal
questionnaires sent to each special care nursery listed
by the Neonatal Nurses’ Association. No data were col›
lected on births outside these maternity units or on the
implementation of policies, and it is not clear who in
each unit completed the questionnaire.19 20 The present
survey, by asking individual midwives to provide infor›
mation, has collected data on how policies are
interpreted by those who implement them, rather than
on how they are interpreted by those who set them.
The response to phase one of this survey was
higher than Asch et al reported as the mean for
surveys of nurses, the closest comparison group (this
survey 79%, Asch et al 61%); the response in phase two
(62%) was comparable to the reported mean.21 More
importantly, the distribution of midwives by health
region was broadly similar in both phases to that of all
midwives working in the NHS at the time the sample
was selected.15–18
Current vitamin K policies
More than 97% of newborn babies are likely to receive
some form of vitamin K routinely, if their parents con›
sent; this is comparable to the 98% reported in a 1993
survey in the British Isles.19 The downward turn
reported in 1993 in the proportion receiving vitamin K
intramuscularly does, however, seem to have been
reversed, with levels reported here likely to be close to
the 57% and 58% figures reported in 1988 and 1982,
and higher than the 38% reported in 1993.19 20 It is dif›
ficult to assess accurately the proportions receiving
vitamin K orally and intramuscularly: numbers receiv›
ing it by each route under selective policies, with differ›
ing criteria for high risk, are unknown, and 11% of
current policies actively encourage parental choice.
There is no clear consensus on which babies should
receive vitamin K intramuscularly.
Neonatal vitamin K administration in the United
Kingdom seems highly unusual in comparison with
other drugs, given the variety of places and number of
times each dose may be recorded. This phenomenon is
not entirely new, however, and was noted in an earlier
study that collected data retrospectively from maternity
records.6
Imputation of vitamin K
It is not known whether previous policies are
accurately recalled by current staff. It is, however, diffi›
cult to feel confident that they always are, given the
variety of combinations of criteria for high risk
reported for current policies. Only three out of 17
specified criteria are included in more than 50% of
selective policies, with additional variation in how some
criteria are defined. Although clinical judgment is
mentioned as a criterion in only 1.8% of policies,
details given by some midwives suggest that it plays a
larger part—one example is making the distinction
between difficult and easy instrumental deliveries.
Judging such distinctions would be difficult for those
collecting data many years later.
Interestingly, many midwives stressed that in their
previous jobs it was the condition of the baby, rather
than policy, that determined if vitamin K was given.
The box lists other reasons stated for not giving
vitamin K intramuscularly when the policy was that it
should be given. Such comments may of course be
biased, as not all midwives chose to add comments to
the questionnaire. However, the comments support
other findings reported here, and previous anecdotal
evidence, that official policies were (and may still be)
open to individual interpretation and were not always
followed rigidly.
The purpose of clinical records is to document
patient care, and variation in recording practices by
policy type, especially if vitamin K was not given,
reflects this. There have been changes over the years,
but, for all time periods, if no written record was made
the most likely reason is that vitamin K was not given.
Table 4 Implementation practices of official policies on vitamin K administration in midwives’ previous jobs (jobs held before 1990).
Values are percentages (numbers)
Year jobs ended
All years
(n=1521)
Before 1979
(n=300)
1980›4
(n=239)
1985›9
(n=369)
After 1990
(n=613)
Policy always followed 68.8 (1047) 75.3 (226) 69.9 (167) 66.4 (245) 66.7 (409)
Recorded if vitamin K given:
Yes 90.9 (1382) 83.7 (251) 87.4 (209) 92.4 (341) 94.8 (581)
Sometimes* 3.6 (54) 5.7 (17) 5.0 (12) 3.3 (12) 2.1 (13)
No 5.6 (85) 10.7 (32) 7.5 (18) 4.3 (16) 3.1 (19)
Recorded if vitamin K not given:
Yes 55.4 (843) 39.3 (118) 44.4 (106) 58.5 (216) 65.7 (403)
Sometimes* 8.9 (135) 9.0 (27) 8.8 (21) 8.1 (30) 9.3 (57)
No 35.7 (543) 51.7 (155) 46.9 (112) 33.3 (123) 25.0 (153)
*Recorded in some circumstances (for example, given by a different route, admission to special care baby unit, parental refusal).
Reasons reported in phase two for not giving vitamin K
intramuscularly to babies who in some studies would be imputed as
receiving it, if policy was selective (given only to babies at high risk)
• Previous policies were simply guidelines
• Wide interpretation of policies—midwives did not like giving babies
injections
• Baby in good condition at birth
• Individual paediatricians had different policies
• Baby admitted to postnatal ward—only given on neonatal unit
• Baby admitted to general practitioner unit—only given on consultant unit
• Confusion over policy
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Relation between socioeconomic deprivation and death
from a first myocardial infarction in Scotland: population
based analysis
Kate Macintyre, Simon Stewart, James Chalmers, Jill Pell, Alan Finlayson, James Boyd,
Adam Redpath, John McMurray, Simon Capewell
Health policy now explicitly addresses the increasing
inequalities arising within many countries.1 Although it
is generally accepted that socioeconomic factors influ›
ence the overall rates of coronary heart disease events,2
studies of case fatality after admission to hospital for
acute myocardial infarction show only modest
socioeconomic gradients.3 By focusing on those who
survive to reach hospital, however, such studies may
underestimate the true influence of socioeconomic
deprivation. Reports suggest that around 70›80% of
deaths within 30 days of a myocardial infarction occur
before admission to hospital, and this proportion
increases with age.4 We therefore examined the effect
of socioeconomic deprivation not only on case fatality
in patients admitted with myocardial infarction but
also on the risk of death before admission.
Participants, methods, and results
Data were obtained from the Scottish Morbidity
Record and General Register Office on all Scottish
residents for whom a first myocardial infarction (code
410, international classification of diseases, 9th
revision) was the principal cause of death or admission
to hospital between 1986 and 1995. This database is
linked to the Registrar General’s data on death certifi›
cates, with an accuracy of 98%. In a 1% sample of
records checked in 1994, acute myocardial infarction
as a principal diagnosis was 97% accurate. First
myocardial infarction was defined as no previous
admission for this event since 1981. Postcodes were
used to assign a Carstairs deprivation category to each
individual, from 1 (least deprived) to 5 (most
deprived).3 These categories are derived from 1991
What is already known on this topic
Neonatal administration of vitamin K by the intramuscular route is
effective in the prevention of haemorrhagic disease in newborn babies
but has been suggested as a possible risk factor for leukaemia in children
A written record confirming that vitamin K has (or has not) been given
is often not found, and some research groups have attempted to
impute a child’s vitamin K status from hospital policy
Nothing is known about how midwives interpret and implement
vitamin K policies
What this study adds
Earlier hospital policies were open to individual interpretation and
they were not always followed
There is considerable variation in current vitamin K policies and
midwifery practice in the United Kingdom and no clear consensus on
which babies should receive vitamin K intramuscularly
A table showing
mortality per 1000
men and women
appears on the
BMJ’s website
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